Cargando…
Benign COVID-19 in an aggressive case of aquaporin-4 Neuromyelitis optica treated with tocilizumab
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498530/ http://dx.doi.org/10.1016/j.jns.2021.119867 |
| _version_ | 1784580181270200320 |
|---|---|
| author | Vecchio, Domizia Solaro, Claudio Virgilio, Eleonora Naldi, Paola Capobianco, Marco Cantello, Roberto |
| author_facet | Vecchio, Domizia Solaro, Claudio Virgilio, Eleonora Naldi, Paola Capobianco, Marco Cantello, Roberto |
| author_sort | Vecchio, Domizia |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8498530 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84985302021-10-08 Benign COVID-19 in an aggressive case of aquaporin-4 Neuromyelitis optica treated with tocilizumab Vecchio, Domizia Solaro, Claudio Virgilio, Eleonora Naldi, Paola Capobianco, Marco Cantello, Roberto J Neurol Sci Article Elsevier 2021-10 2021-10-08 /pmc/articles/PMC8498530/ http://dx.doi.org/10.1016/j.jns.2021.119867 Text en Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Vecchio, Domizia Solaro, Claudio Virgilio, Eleonora Naldi, Paola Capobianco, Marco Cantello, Roberto Benign COVID-19 in an aggressive case of aquaporin-4 Neuromyelitis optica treated with tocilizumab |
| title | Benign COVID-19 in an aggressive case of aquaporin-4 Neuromyelitis optica treated with tocilizumab |
| title_full | Benign COVID-19 in an aggressive case of aquaporin-4 Neuromyelitis optica treated with tocilizumab |
| title_fullStr | Benign COVID-19 in an aggressive case of aquaporin-4 Neuromyelitis optica treated with tocilizumab |
| title_full_unstemmed | Benign COVID-19 in an aggressive case of aquaporin-4 Neuromyelitis optica treated with tocilizumab |
| title_short | Benign COVID-19 in an aggressive case of aquaporin-4 Neuromyelitis optica treated with tocilizumab |
| title_sort | benign covid-19 in an aggressive case of aquaporin-4 neuromyelitis optica treated with tocilizumab |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498530/ http://dx.doi.org/10.1016/j.jns.2021.119867 |
| work_keys_str_mv | AT vecchiodomizia benigncovid19inanaggressivecaseofaquaporin4neuromyelitisopticatreatedwithtocilizumab AT solaroclaudio benigncovid19inanaggressivecaseofaquaporin4neuromyelitisopticatreatedwithtocilizumab AT virgilioeleonora benigncovid19inanaggressivecaseofaquaporin4neuromyelitisopticatreatedwithtocilizumab AT naldipaola benigncovid19inanaggressivecaseofaquaporin4neuromyelitisopticatreatedwithtocilizumab AT capobiancomarco benigncovid19inanaggressivecaseofaquaporin4neuromyelitisopticatreatedwithtocilizumab AT cantelloroberto benigncovid19inanaggressivecaseofaquaporin4neuromyelitisopticatreatedwithtocilizumab |